Loading…
Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency
Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two u...
Saved in:
Published in: | European journal of immunology 1998-02, Vol.28 (2), p.589-598 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3 |
container_end_page | 598 |
container_issue | 2 |
container_start_page | 589 |
container_title | European journal of immunology |
container_volume | 28 |
creator | Nonoyama, Shigeaki Etzioni, Amos Toru, Hano Ruggerie, Dennis P. Lewis, David Pollack, Shimon Aruffo, Alejandro Yata, Jun‐Ichi Ochs, Hans D. |
description | Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two unrelated families. CD40 ligand expression by maximally activated BLS T cells was diminished. This abnormality may represent immunological naïveté rather than a general T cell defect, since expression of activation marker CD69 and proliferative responses to PHA or anti‐CD3 were normal, and BLS T cells primed and restimulated in vitro expressed normal amounts of CD40 ligand. BLS B cells proliferated and produced IgE if stimulated with anti‐CD40 or soluble CD40 ligand and IL‐4. Activation of BLS B cells with soluble CD40 ligand and IL‐4 induced normal expression of activation markers, although MHC class II expression remained absent. Depressed antibody titers, lack of amplification and failure to undergo isotype switching in response to immunization with bacteriophage ϕ × 174 demonstrated defective T cell help. We conclude that BLS B cells are functionally normal if appropriately stimulated, and that the defective humoral immunity observed may be related to diminished expression of CD40 ligand on BLS T cells. |
doi_str_mv | 10.1002/(SICI)1521-4141(199802)28:02<589::AID-IMMU589>3.0.CO;2-J |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79754002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16410256</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS0EKkvhIyD5hNpDlrHjJPZSIaos0FRd7QEqIXGwnGSWNcqfJXYoufDZ8WqXXkDqxdbMvPfG8o-QdwzmDIC_PvtU5MU5SziLBBPsjCklgZ9zuQB-kUi1WFwWy6hYrW5D8Taewzxfv-HR9SMyuzc9JjMAJiIerE_JM-e-A4BKE3VCTlQQQapm5PfStrazbos1xV-7AZ2zfUf7Dc2XAmhjv5mupq2ZaNV3frDl6JH6nvot0ho3WHn7E-l2bPvBNNS27dhZP1Hb0Z3xFjvv6J31W7q6ymnVGOdoUeyNtgrDanpOnmxM4_DF8T4ltx_ef86vopv1xyK_vIkqIbmKeCkxU5XJSgBpWFpmHNIyNlwmyDARUnGWKcliiDlmLNSCm7JMhMK6VlkZn5JXh9zd0P8Y0XndWldh05gO-9HpTGWJCB__oJClggFP0iD8chBWQ-_cgBu9G2xrhkkz0HuGWu8Z6j0OvcehDww1lzqcAZvWgaE-MtSxBp2vNdfXIfrl8Q1j2WJ9H3yEFuZfD_M72-D0z96H1v5_699W_Ad3-rho</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16410256</pqid></control><display><type>article</type><title>Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Nonoyama, Shigeaki ; Etzioni, Amos ; Toru, Hano ; Ruggerie, Dennis P. ; Lewis, David ; Pollack, Shimon ; Aruffo, Alejandro ; Yata, Jun‐Ichi ; Ochs, Hans D.</creator><creatorcontrib>Nonoyama, Shigeaki ; Etzioni, Amos ; Toru, Hano ; Ruggerie, Dennis P. ; Lewis, David ; Pollack, Shimon ; Aruffo, Alejandro ; Yata, Jun‐Ichi ; Ochs, Hans D.</creatorcontrib><description>Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two unrelated families. CD40 ligand expression by maximally activated BLS T cells was diminished. This abnormality may represent immunological naïveté rather than a general T cell defect, since expression of activation marker CD69 and proliferative responses to PHA or anti‐CD3 were normal, and BLS T cells primed and restimulated in vitro expressed normal amounts of CD40 ligand. BLS B cells proliferated and produced IgE if stimulated with anti‐CD40 or soluble CD40 ligand and IL‐4. Activation of BLS B cells with soluble CD40 ligand and IL‐4 induced normal expression of activation markers, although MHC class II expression remained absent. Depressed antibody titers, lack of amplification and failure to undergo isotype switching in response to immunization with bacteriophage ϕ × 174 demonstrated defective T cell help. We conclude that BLS B cells are functionally normal if appropriately stimulated, and that the defective humoral immunity observed may be related to diminished expression of CD40 ligand on BLS T cells.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/(SICI)1521-4141(199802)28:02<589::AID-IMMU589>3.0.CO;2-J</identifier><identifier>PMID: 9521069</identifier><language>eng</language><publisher>Weinheim: WILEY‐VCH Verlag GmbH</publisher><subject>Antibodies, Viral - biosynthesis ; B cell ; Bacteriophage phi X 174 - immunology ; CD40 Antigens - physiology ; CD40 Ligand ; Female ; Helper function ; Histocompatibility Antigens Class II - biosynthesis ; Histocompatibility Antigens Class II - blood ; Humans ; Immunodeficiency ; Immunoglobulins - biosynthesis ; Immunoglobulins - blood ; Immunoglobulins - deficiency ; Infant ; Ligands ; Lymphocyte Activation ; Male ; Membrane Glycoproteins - biosynthesis ; MHC class II ; Severe Combined Immunodeficiency - blood ; Severe Combined Immunodeficiency - immunology ; T cell</subject><ispartof>European journal of immunology, 1998-02, Vol.28 (2), p.589-598</ispartof><rights>1998 WILEY‐VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9521069$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nonoyama, Shigeaki</creatorcontrib><creatorcontrib>Etzioni, Amos</creatorcontrib><creatorcontrib>Toru, Hano</creatorcontrib><creatorcontrib>Ruggerie, Dennis P.</creatorcontrib><creatorcontrib>Lewis, David</creatorcontrib><creatorcontrib>Pollack, Shimon</creatorcontrib><creatorcontrib>Aruffo, Alejandro</creatorcontrib><creatorcontrib>Yata, Jun‐Ichi</creatorcontrib><creatorcontrib>Ochs, Hans D.</creatorcontrib><title>Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two unrelated families. CD40 ligand expression by maximally activated BLS T cells was diminished. This abnormality may represent immunological naïveté rather than a general T cell defect, since expression of activation marker CD69 and proliferative responses to PHA or anti‐CD3 were normal, and BLS T cells primed and restimulated in vitro expressed normal amounts of CD40 ligand. BLS B cells proliferated and produced IgE if stimulated with anti‐CD40 or soluble CD40 ligand and IL‐4. Activation of BLS B cells with soluble CD40 ligand and IL‐4 induced normal expression of activation markers, although MHC class II expression remained absent. Depressed antibody titers, lack of amplification and failure to undergo isotype switching in response to immunization with bacteriophage ϕ × 174 demonstrated defective T cell help. We conclude that BLS B cells are functionally normal if appropriately stimulated, and that the defective humoral immunity observed may be related to diminished expression of CD40 ligand on BLS T cells.</description><subject>Antibodies, Viral - biosynthesis</subject><subject>B cell</subject><subject>Bacteriophage phi X 174 - immunology</subject><subject>CD40 Antigens - physiology</subject><subject>CD40 Ligand</subject><subject>Female</subject><subject>Helper function</subject><subject>Histocompatibility Antigens Class II - biosynthesis</subject><subject>Histocompatibility Antigens Class II - blood</subject><subject>Humans</subject><subject>Immunodeficiency</subject><subject>Immunoglobulins - biosynthesis</subject><subject>Immunoglobulins - blood</subject><subject>Immunoglobulins - deficiency</subject><subject>Infant</subject><subject>Ligands</subject><subject>Lymphocyte Activation</subject><subject>Male</subject><subject>Membrane Glycoproteins - biosynthesis</subject><subject>MHC class II</subject><subject>Severe Combined Immunodeficiency - blood</subject><subject>Severe Combined Immunodeficiency - immunology</subject><subject>T cell</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkU9v1DAQxS0EKkvhIyD5hNpDlrHjJPZSIaos0FRd7QEqIXGwnGSWNcqfJXYoufDZ8WqXXkDqxdbMvPfG8o-QdwzmDIC_PvtU5MU5SziLBBPsjCklgZ9zuQB-kUi1WFwWy6hYrW5D8Taewzxfv-HR9SMyuzc9JjMAJiIerE_JM-e-A4BKE3VCTlQQQapm5PfStrazbos1xV-7AZ2zfUf7Dc2XAmhjv5mupq2ZaNV3frDl6JH6nvot0ho3WHn7E-l2bPvBNNS27dhZP1Hb0Z3xFjvv6J31W7q6ymnVGOdoUeyNtgrDanpOnmxM4_DF8T4ltx_ef86vopv1xyK_vIkqIbmKeCkxU5XJSgBpWFpmHNIyNlwmyDARUnGWKcliiDlmLNSCm7JMhMK6VlkZn5JXh9zd0P8Y0XndWldh05gO-9HpTGWJCB__oJClggFP0iD8chBWQ-_cgBu9G2xrhkkz0HuGWu8Z6j0OvcehDww1lzqcAZvWgaE-MtSxBp2vNdfXIfrl8Q1j2WJ9H3yEFuZfD_M72-D0z96H1v5_699W_Ad3-rho</recordid><startdate>199802</startdate><enddate>199802</enddate><creator>Nonoyama, Shigeaki</creator><creator>Etzioni, Amos</creator><creator>Toru, Hano</creator><creator>Ruggerie, Dennis P.</creator><creator>Lewis, David</creator><creator>Pollack, Shimon</creator><creator>Aruffo, Alejandro</creator><creator>Yata, Jun‐Ichi</creator><creator>Ochs, Hans D.</creator><general>WILEY‐VCH Verlag GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199802</creationdate><title>Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency</title><author>Nonoyama, Shigeaki ; Etzioni, Amos ; Toru, Hano ; Ruggerie, Dennis P. ; Lewis, David ; Pollack, Shimon ; Aruffo, Alejandro ; Yata, Jun‐Ichi ; Ochs, Hans D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Antibodies, Viral - biosynthesis</topic><topic>B cell</topic><topic>Bacteriophage phi X 174 - immunology</topic><topic>CD40 Antigens - physiology</topic><topic>CD40 Ligand</topic><topic>Female</topic><topic>Helper function</topic><topic>Histocompatibility Antigens Class II - biosynthesis</topic><topic>Histocompatibility Antigens Class II - blood</topic><topic>Humans</topic><topic>Immunodeficiency</topic><topic>Immunoglobulins - biosynthesis</topic><topic>Immunoglobulins - blood</topic><topic>Immunoglobulins - deficiency</topic><topic>Infant</topic><topic>Ligands</topic><topic>Lymphocyte Activation</topic><topic>Male</topic><topic>Membrane Glycoproteins - biosynthesis</topic><topic>MHC class II</topic><topic>Severe Combined Immunodeficiency - blood</topic><topic>Severe Combined Immunodeficiency - immunology</topic><topic>T cell</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nonoyama, Shigeaki</creatorcontrib><creatorcontrib>Etzioni, Amos</creatorcontrib><creatorcontrib>Toru, Hano</creatorcontrib><creatorcontrib>Ruggerie, Dennis P.</creatorcontrib><creatorcontrib>Lewis, David</creatorcontrib><creatorcontrib>Pollack, Shimon</creatorcontrib><creatorcontrib>Aruffo, Alejandro</creatorcontrib><creatorcontrib>Yata, Jun‐Ichi</creatorcontrib><creatorcontrib>Ochs, Hans D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nonoyama, Shigeaki</au><au>Etzioni, Amos</au><au>Toru, Hano</au><au>Ruggerie, Dennis P.</au><au>Lewis, David</au><au>Pollack, Shimon</au><au>Aruffo, Alejandro</au><au>Yata, Jun‐Ichi</au><au>Ochs, Hans D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>1998-02</date><risdate>1998</risdate><volume>28</volume><issue>2</issue><spage>589</spage><epage>598</epage><pages>589-598</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two unrelated families. CD40 ligand expression by maximally activated BLS T cells was diminished. This abnormality may represent immunological naïveté rather than a general T cell defect, since expression of activation marker CD69 and proliferative responses to PHA or anti‐CD3 were normal, and BLS T cells primed and restimulated in vitro expressed normal amounts of CD40 ligand. BLS B cells proliferated and produced IgE if stimulated with anti‐CD40 or soluble CD40 ligand and IL‐4. Activation of BLS B cells with soluble CD40 ligand and IL‐4 induced normal expression of activation markers, although MHC class II expression remained absent. Depressed antibody titers, lack of amplification and failure to undergo isotype switching in response to immunization with bacteriophage ϕ × 174 demonstrated defective T cell help. We conclude that BLS B cells are functionally normal if appropriately stimulated, and that the defective humoral immunity observed may be related to diminished expression of CD40 ligand on BLS T cells.</abstract><cop>Weinheim</cop><pub>WILEY‐VCH Verlag GmbH</pub><pmid>9521069</pmid><doi>10.1002/(SICI)1521-4141(199802)28:02<589::AID-IMMU589>3.0.CO;2-J</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2980 |
ispartof | European journal of immunology, 1998-02, Vol.28 (2), p.589-598 |
issn | 0014-2980 1521-4141 |
language | eng |
recordid | cdi_proquest_miscellaneous_79754002 |
source | Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list) |
subjects | Antibodies, Viral - biosynthesis B cell Bacteriophage phi X 174 - immunology CD40 Antigens - physiology CD40 Ligand Female Helper function Histocompatibility Antigens Class II - biosynthesis Histocompatibility Antigens Class II - blood Humans Immunodeficiency Immunoglobulins - biosynthesis Immunoglobulins - blood Immunoglobulins - deficiency Infant Ligands Lymphocyte Activation Male Membrane Glycoproteins - biosynthesis MHC class II Severe Combined Immunodeficiency - blood Severe Combined Immunodeficiency - immunology T cell |
title | Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T06%3A24%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diminished%20expression%20of%20CD40%20ligand%20may%20contribute%20to%20the%20defective%20humoral%20immunity%20in%20patients%20with%20MHC%20class%20II%20deficiency&rft.jtitle=European%20journal%20of%20immunology&rft.au=Nonoyama,%20Shigeaki&rft.date=1998-02&rft.volume=28&rft.issue=2&rft.spage=589&rft.epage=598&rft.pages=589-598&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/(SICI)1521-4141(199802)28:02%3C589::AID-IMMU589%3E3.0.CO;2-J&rft_dat=%3Cproquest_cross%3E16410256%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16410256&rft_id=info:pmid/9521069&rfr_iscdi=true |